Sort
64,565 grants matching “drug discovery”
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$1,991,523Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Molecular Profiling of Clinical Specimens
$1,991,384Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
CENTER OF EXCELLENCE FOR PROSTATE CANCER RESEARCH, EDUCATION AND COMMUNITY SERVIC
$1,991,327Shafiq A Khan · Clark Atlanta University · P20 · FY2011 · MD
Growth Factor Imaging
$1,990,651Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Translational Drug Abuse Prevention Center
$1,990,511Patricia Chamberlain · Oregon Social Learning Center, Inc. · P50 · FY2016 · DA
NATIONAL BIOMEDICAL COMPUTATION RESOURCE
$1,990,191Rommie E Amaro · University Of California, San Diego · P41 · FY2014 · GM
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,989,733Aaron Esser-Kahn · University Of Chicago · N01 · FY2024 · AI
Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity
$1,989,374Bernhard O Palsson · University Of California, San Diego · U01 · FY2016 · AI
Biology and Novel Therapeutics of Cardiovascular Peptides
$1,988,914John C Burnett · Mayo Clinic Rochester · P01 · FY2011 · HL
Integrative Oncogenomics of Multiple Myeloma
$1,988,528Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2015 · CA
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
$1,988,500David H Perlmutter · Washington University · P01 · FY2019 · DK
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models
$1,987,779Ross Leigh Cagan · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · OD
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models
$1,987,420Ross Leigh Cagan · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · OD
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$1,987,010Matthew G Dorsey · University Of California, San Francisco · U19 · FY2022 · AI
DCTD Computer Support
$1,986,559David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
IGF::OT::IGF SBIR PHASE II TOPIC 314, TITLE: VALIDATION OF THE HEMOSHEAR TUMOR MICROENVIRONMENT SYSTEM FOR DRUG DISCOVERY AND DEVELOPMENT
$1,985,884Brian Wamhoff · Hemoshear Therapeutics, Llc · N44 · FY2015 · CA
Pharmacological Treatment of Retinal Diseases
$1,983,634Krzysztof Palczewski · Case Western Reserve University · R24 · FY2012 · EY
TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT
$1,983,627Caroline C Sigman · Ccs Associates, Inc. · N02 · FY2015 · CA
TARGETING OF TUMOR VASCULATURE
$1,982,836Burnham Institute For Medical Research · P01 · FY2004 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$1,982,660John E Wagner · University Of Minnesota · P01 · FY2024 · CA
On-Demand Pharmacological Contraception by Blocking ADCY 10
$1,982,625Lonny R Levin · Weill Medical Coll Of Cornell Univ · P50 · FY2020 · HD
On-Demand Pharmacological Contraception by Blocking ADCY 10
$1,982,625Lonny R Levin · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · HD
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,982,040Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Harvard-wide Program on Antibiotic Resistance
$1,982,034Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2018 · AI
EFRI-CBE Topic B: Biofunctionalized Devices - On Chip Signaling and "Rewiring" Bacterial Cell-Cell Communication
$1,980,984William E Bentley · University Of Maryland Biotechnology Institute · · FY2007 · ENG